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Objectives: The aim of this study was to compare the behaviour of mesothelial cells (MC) to that of endothelial cells (EC) 
when seeded onto a PTFE prosthesis coated with a fibroblastic matrix. 
DeMgn;-material nd methods: Three study groups were examined: a control group (Control) of PTFE prostheses with 
a fibroblast f~atrix (n = 8); Group EC, PTFE prostheses eeded with EC on a fibroblastic matrix (n = 8); and Group MC, 
PTFE prostheses seeded with MC on a fibroblastic matrix (n = 8). All cell types were labelled with 111In (100 ].~Ci/ml) 24 
h after seeding, when the cells had formed a monolayer on the prosthetic surface. Radioactive l vels were measured at 2, 4, 
6, and 24 h. 
Results: Both EC and MC showed optimal adherence. The MC had a better adioactive uptake and retention than the EC. 
The number of EC and MC cells that remained adherent to the matrix was large enough to ensure complete covering of the 
prosthetic surface. 
Conclusion: The use of MC is therefore feasible as an optimal alternative for achieving a natural covering on vascular 
prostheses prepared with a fibroblastic matrix. 
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Introduction 
The problems involved in seeding cells on medium- 
sized and small-sized vascular prostheses concern the 
optimal source for cells and the optimal substrate for 
ensuring their fixation to the prosthetic material. In 
the laboratory, human umbilical cord vein has been 
found to be an ideal source of endothelial cells (EC) for 
studies in vitro. Jugular vein has also been used for this 
purpose in experimental nimals. 1 In human beings it 
is preferable to conserve the main leg veins because 
they are still the best option for bypass and vascular 
replacement surgery. Nonetheless, aphenous vein 2 
and even varicose veins 3 have been used as a source of 
EC. However, these sources are clearly insufficient, 5 
particularly when large vascular prosthetic surfaces 
have to be covered. 
*Please address all correspondence to:Prof. Juan M. Bell6n, Dept. of 
Morphological Sciences and Surgery, Carret. N.II, Km 33,6. Alcal~ 
de Henares, 28871 Madrid, Spain 
An alternative to EC may be mesothelial cells (MC) 
obtained from the omentum. The identity of mesothe- 
lial cells is disputed. Some authors 5-8 claim they are 
endothelial because their come from microcirculation 
vessels, whereas others ~-n classify them as mesothe- 
12,13 lial, and a third group of authors ' state that criteria 
are insufficient for classifying them as either endothe- 
lial or mesothelial. In an ear l ier  study) 14 we found that 
MC are positive for EC antibodies and for antibodies 
specific to smooth muscle cells (anti-alpha ctin and 
anti-total actin). We also confirmed 9'1s the presence of 
optimal prostacyclin production. 
A no less important problem is to ensure the 
adherence of the cells seeded on prosthetic materials. 
In an earlier study by our group using a fibroblastic 
matrix, 16 cellular adherence improved because the 
resulting monolayer of seeded EC was more stable. 
Based on the findings of previous tudies, this study 
compared lnln labelled EC and MC seeded on a 
fibroblastic matrix positioned between the cells and 
the prosthetic material. 
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Materials and Methods 
Ceil extraction and culture 
(a) Mesothelial cells. The MC were obtained from 30-40 
g fragments of human omentum obtained from 
donors in the course of elective abdominal surgery. 
The omental fragments were transported to the 
laboratory immersed in minimum essential medium 
(MEM) (Gibco BRL) supplemented with antibiotics 
(100 000 IU / ml penicillin / 10 000 ]zg/ml streptomycin) 
(Gibco BRL) and antimycotics (25/~g/ml fungizone) 
(Gibco BRL). Fragments were processed following the 
methods described by Kern et al. 17 with some 
modifications. 
In the laborator)~ the omental fragments were 
incubated in a solution of 0.1% type I collagenase 
(Worthington) in MEM, with agitation (100 oscilla- 
tions/min) for 20 min. Surplus omental fragments 
were removed and the cell suspension was centri- 
fuged at 200 g for 7 rain. The supernatant was 
eliminated and the resulting cellular precipitate was 
resuspended in 5 ml of Medium 199 (M-199) (Gibco 
BRL) supplemented with 20% fetal bovine serum 
(Gibco BRL), antibiotics (100000 IU/ml penicillin/ 
10000/~g/ml streptomycin) (Gibco BRL), 10 mM Hepes 
(Gibco BRL), 2 mM c-glutamine (Gibco BRL), and 
sodium heparin (90/zg/ml) (Roche). The cell suspen- 
sion was transferred to Nunclon 25 cm 2 culture flasks 
and incubated in a culture oven (5% CO2) at 37°C until 
a confluent monolayer had formed on the culture 
surface. 
(b) Endothelial cells. The EC were obtained from human 
umbilical vein and placed in culture following the 
methods described by Gimbrone. 18 In the laboratory, 
the inner vein was washed several times with MEM 
under sterile conditions. The vein was then filled with 
a 0.1% solution of type I collagenase (Worthington) in
MEM and incubated for 15 min at 37°C. The cell 
suspension was collected in a 50ml conical centrifuge 
tube (Falcon) and centrifuged at 200 g for 7 min. The 
precipitate was resuspended in 5 ml MEM and 
centrifuged again under the same conditions. This last 
step was repeated three times to eliminate any blood 
components that may have been released during 
enzymatic digestion. After the final centrifugation, the 
EC were resuspended in 5 ml of M-199 (Gibco BRL) 
supplemented with 20% bovine fetal serum (Gibco 
BRL), antibiotics (100 000 IU/ml penicillin/10 000 
/zg/ml streptomycin) (Gibco BRL), 10 mM Hepes 
(Gibco BRL), 2 mM c-glutamine (Gibco BRL), endothe- 
lial cell growth factor (20/~g/ml) (ECGF) (Sigma), and 
sodium heparin (90/~g/ml) (Roche), placed in a 25 
cm 2 culture flask (Nunclon), and incubated at 37°C in 
a CO2 oven (5% CO2). 
(c) Fibroblasts. A small skin sample (1 cm × 0.5 cm) 
was obtained from donor patients in the same opera- 
tion that yielded MC and EC. This small skin fragment 
was submerged immediately in MEM supplemented 
as described, then transported to the laboratory. 
Under sterile conditions the explants were placed in 
25 cm 2 culture flasks containing 5 ml of McCoy's 
medium (Gibco BRL) supplemented with 10% bovine 
fetal serum (Gibco BRL), antibiotics (100 000 IU/ml 
penicillin/10 000/zg/ml streptomycin) (Gibco BRL), 
10 mM Hepes (Gibco BRL), and 2 mM L-glutamine 
(Gibco BRL). The culture flasks containing the 
explants were incubated at 37°C in a 5% CO2 oven. 
In all cases, the culture medium was changed every 
2 days until a confluent monolayer had formed on the 
culture surface. Once the cellular monolayer had 
formed, cellular subcultures were made to obtain 
enough cells to completely cover the prosthetic surface 
by seeding. These subcultures were made by treating 
the cellular monotayer with a suspension of 1% 
trypsin-EDTA (Gibco BRL) in HBSS free of Ca 2+ and 
Mg 2+ (Gibco BRL) for 5 min at 37°C. After incubation, 
the proteolytic enzyme was inactivated by adding 
medium (M-199 for EC and MC cultures; McCoy's 
medium for fibroblast cultures) supplemented with 
fetal calf serum (Gibco BRL). The cell suspension was 
divided into culture flasks at a ratio of 1:2 to 1:3. All 
the cells used in this study came from the first 
subculture. 
Cell count identification and prostacyclin production 
The number of viable cells was determined using 
trypan blue and counted in a Neubauer chamber. Cells 
were identified using immunohistochemical tech- 
niques: anti-CD34 antibodies (Serotec), anti-factor VIII 
(Biomeda) (specific for EC), anti-cytokeratin 18 (Bio- 
genesis) (normally used for MC identification), anti- 
vimentin (Biomeda), anti-desmin, anti-actin and anti- 
total actin (all courtesy of Professor Gabiani). 
Immunohistochemical reactions were detected with 
commercial kits using FITC (immunofluorescence) 
(Nordic Immunology), ABC (StreptoAvidin-Biotin 
Complex) (Sigma), and PAP (Peroxidase-Anti-Perox- 
idase) (Dako) techniques. 
MC and EC production of prostacyclin was deter- 
mined using radioimmunoassay techniques to meas- 
ure the level of 6-keo-prostaglandin FI~, a stable 
intermediate in the prostacyclin synthesis pathway. 
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This intermediate compound was detected using the 
method described in the commercial radioimmu- 
noassay kit (Amersham). 
Cell seeding and labelling 
The seeding chamber was constructed following the 
methods reported by Budd et al. 19 
Fibroblasts from the first subculture were lifted 
from the surface of the culture flask using an enzy- 
matic treatment with trypsin-EDTA solution following 
the method indicated for subcultures. A small aliquot 
of the cell suspension was separated for a viable cell 
count o determine the number of cells to be seeded in 
each seeding chamber. Before seeding, all prostheses 
were incubated for I h at 37°C with 100/~1 of a solution 
containing 20/xg/ml of fibronectin (Sigma) in MEM. 
Excess fibronectin was eliminated and the prosthesis 
surface was seeded with a cell suspension containing 
2 × 105 fibroblasts/ml. Once seeded, the prostheses 
were incubated at 37°C in a CO2 oven (5% CO2) for 24 
h. When the fibroblastic monolayer had formed on the 
prosthetic surface, it was fixed with 5% glycerol. This 
produced a fibroblastic matrix for EC and MC 
seeding. 
After the fibroblastic matrix was created on PTFE, 
MC and EC from the first subculture were raised from 
the surface of the culture flask as described earlier. The 
resulting cell suspensions were centrifuged at 200 g 
for 7 min, resuspended in complete M-199, and seeded 
on the fibroblastic matrix after it was incubated with 
fibronectin (20/xg/ml) at 37°C for i h. A small aliquot 
was separated to make the cell count and the EC and 
MC were seeded at a density of 1.5-2 × 105 cells/ 
ml. 
In the 24 h after seeding, when the cells had formed 
a monolayer on the surface of the prosthesis, cells 
were labelled with 111In-oxine (100 /xCi/ml). The 
radioactive substance was added to each well then 
incubated for 15 min at room temperature. The 
surplus radioactive substance then was removed by 
washing three times with MEM. 
Measurement of the surface covering 
The specimens obtained were fixed in 3% glutar- 
aldehyde for 2 h then introduced into Milloning buffer 
(pH 7.3). The samples were dehydrated in a graduated 
acetone series, brought o critical point in a Polaron 
E-3000 with CO 2, metallised in palladium gold, and 
studied under a Zeiss 950 DSM scanning electron 
microscope. Measurements of the surface covered 
were taken using 16 microphotographs (100 × ) of 
each sample observed by scanning electron micros- 
copy. Each sample was divided into four quadrants 
and four microphotographs were taken of each quad- 
rant at random. The microphotographs were then 
subjected to image analysis (Microm) to determine the 
surface covered cells in proportion to the total surface. 
Results were expressed as percentages. 
Experimental design 
Three study groups were set up to compare the 
behaviour of MCs to that of ECs when seeded onto a 
PTFE prosthesis coated with a fibroblastic matrix: 
(a) Control group: PTFE vascular prostheses 
with an unseeded fibroblastic matrix 
(n = 8). 
(b) EC group: PTFE vascular prostheses 
seeded with EC on a fibroblastic matrix 
(n = 8). 
(c) MC group: PTFE vascular prostheses 
seeded with MC on a fibroblastic matrix 
(n = 8). 
In all the groups radioactive substance uptake was 
measured under the same conditions. The study times 
were 2, 4, 6, and 24 h after the formation of a 
monolayer on the prosthetic surface. At each study 
time the culture medium was removed and the 
prostheses were washed three times with PBS buffer 
to eliminate cells that had separated from the pros- 
thetic surface. 
Statistical analysis was made using the Mann- 
Whitney U-test for comparisons between groups and 
the Wilcoxon test for intragroup comparisons. 
Results 
Cell cultures 
Fibroblasts. The fibroblasts in culture had a morphol- 
ogy that clearly differed from the EC and MC, 
characterised by a spindle shape and concentric 
colony growth. Cellular secretion in culture was 
manifested by intracytoplasmatic vacuolised clumps 
and extracellular secretion i  culture by a material that 
was discreetly refringent on reverse microscopy. 
Endothelial cells. The EC in culture had an elongated 
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morphology with large, round or oval nuclei and one, 
two, or three mucleoli. The EC formed a monolayer 
that showed a characteristic cobblestone appearance 
after 7-10 days of culture. 
MesotheliaI cells. The MC behaved well in culture, 
forming a confluent monolayer on the flask surface a 
few days after seeding. The monolayer consisted of 
polygonal cells with a rounded nucleus. This cells 
were surrounded by an abundant glycocalyx. 
All the cell types had the same behaviour and 
morphologic haracteristics after the first subculture. 
In every case, the trypan blue test revealed a viability 
rate that was sufficient o guarantee ffective seeding 
on the prosthetic material after the first subculture. 
Cell identification and prostacyclin production 
The EC were clearly positive for anti-CD34 and anti- 
factor VIII antibodies, and the fibroblasts were pos- 
itive for anti-vimentin antibodies. The MC were 
positive for all antibodies assayed. MC positivity was 
strong for anti-cytokeratin 18, anti-desmin, anti-actin, 
and anti-total actin antibodies. Both EC and MC 
produced high prostacyclin levels in the primary 
cultures and in the first subcultures (>5 ng/ml); 
prostacyclin activity was not detected in the fibroblast 
cultures. 
Ceil seeding and labelling 
Fibroblasts. The fibroblasts seeded on PTFE had an 
initial morphology that was rounded with numerous 
spiked prolongations that contacted each other and 
formed a typical cellular reticulum. After cytoplas- 
matic organisation, the flbroblasts formed a cell 
covering and the cells acquired a typical spindle- 
shaped morphology. They soon began an intense 
secretory activity that gave the cell covering a illa- 
mentous, fibrillar aspect on its apical face and pro- 
duced an abundant glycocalyx on the fibroblastic 
layer. The fibroblasts covered the entire prosthesis 
with a stable monolayer 18-24 h after seeding. Once 
the monolayer had formed, it was fixed to the 
prosthetic surface with 5% glycerol. This produced a
rough surface suitable as a matrix for seeding the 
other cell types. 
Endothelial cells. The EC had good adherence to the 
fibroblastic matrix 24 h after seeding. At this time, the 
prosthetic surface was covered totally by a confluent 
endothelial layer (Fig. la). 
Mesothelial cells. The MC formed a stable cell layer on 
the fibroblastic matrix 24 h after seeding. The cells of 
the layer were extended on the matrix. Some had a 
spherical morphology and there was a typical appear- 
ance of cells in different stages of division (Fig. lb). 
When the control specimens were incubated with 
mIn-oxine, the fibroblasts at first (t = 0) incorporated 
Fig. 1. Cell covering of the prosthetic surface before rain labelling. (a) EC adhered to the fibroblastic matrix form a confluent monolayer 
on the PTFE surface 24 h after seeding ( x 200). 0o) MC seeded on the fibroblastic matrix form a confluent monolayer 24 h after seeding. 
( × 200). Reproduced here at 70%. 
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large amounts of rain, attaining 99.48% effectiveness 
in labelling. After the first wash (t = 2 h), the amount of 
radioactive substance remaining on the surface of the 
matrix decreased (82% retention) and continued to 
decrease throughout the study (53% at t=24 h). 
Radioactive Substance retention by the seeded surface 
decreased over time in every study group (Table 1). In 
the EC seeded on the fibroblastic matrix, 111In uptake 
of 72% and radioactive substance retention decreased 
progressively to 29% at the end of the study. These 
results are shown in Table 1. The differences in rain 
retention were significant (p < 0.01) at all study times 
except between 4 and 6 h. The EC seeded on the 
fibroblastic matrix had a significantly lower (p < 0.01) 
rain retention at all study times than the control group 
(Fig. 2). The MC seeded on the fibroblastic matrix also 
had a lower 111In retention than the controls, but not as 
low as the EC (p< 0.01) (Fig. 2). Comparing rain 
retention by the EC and MC, the MC had a larger 
initial radioactive substance uptake and lesser release 
throughout he study time than the EC. Therefore, 
111In retention was significantly greater (p < 0.05) in the 
Table 1. Retention of mIn-oxine by the different groups of 
prostheses in the first 24 h after formation of a monolayer on the 
prosthetic surface (Mean-+S.D.). 
t(h) Control (%) Group EC (%) Group MC (%) 
0 99.5_+9.7 41.9+3.4 71.9+8.1 
2 82.2+7.3 19.3_+1.9 62.9+7.2 
4 76.5-+7.1 15.2+1.3 38.1+4.0 
6 74.3-+6.4 13.9+2.9 32.4+3.9 
24 52.7+4.3 10.5+2.7 29.2+2.5 
MC group than in the EC group throughout the study 
(Fig. 2). 
Surface covering 
Forty-eight hours after seeding, both the EC and MC 
seeded prostheses showed a large loss of rain labelled 
cells, but the prosthetic surface with fibroblastic 
matrix was covered totally by cells which formed a 
typical confluence monolayer that appeared to be very 
stable (Fig. 3). No significant differences were found 
between EC and MC in terms of the prosthetic surface 
covered (100% in both cases). 
Discussion 
Sources of cells for seeding prostheses have been 
widely reviewed in the literature. 4 The possibility of 
using cell types that have characteristics similar to EC, 
such as MC, has strong practical advantages. 
Earlier studies 2°-22 demonstrated a better endothe- 
lial function when the cells on which the endothelium 
formed were similar to natural subendothelial cells. 
Although the use of fibronectin (20/xg/ml) has given 
good results, 23 the interposition of a fibroblastic 
matrix yielded our best results for EC seeding. 16 
Nonetheless, the fibroblast matrix was found in earlier 
studies to be stable for only the first 24 h after 
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Fig. 2. Retention of l~lIn over time: Significant differences (p< 0.01) were observed between the control prostheses and the EC-seeded on 
the fibroblastic matrix (Fb + EC). Significant differences (p < 0.01) were observed between the control prostheses and the MC-seeded on the 
fibroblastic matrix (Fb + MC). The MC seeded on the fibroblastic matrix (Fb + MC) retained more radioactive substance (p< 0.05) than the 
EC seeded on the fibroblastic matrix. (m) control; (71) Fb + EC; ([]) Fb + MC. 
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seeding. 24 This lead us to fix the fibroblast layer with 
ethanol but ethanol modifies the permeability of the 
prosthesis, 25so it was later replaced by glycerol, which 
fixes the fibroblast layer to the surface of the bio- 
material without modifying its structure. 
In the current study, MC and EC adherence to the 
fibroblastic matrix was optimal. The MC formed a 
stable monolayer on the fibroblast matrix in the first 24 
h after seeding and the monolayer emained on the 
prosthetic surface throughout he study time. 111In- 
oxine labelling showed that the fibroblastic matrix had 
a high radioactive substance uptake, superior to that 
of EC and MC. The sustained high radioactive 
substance retention levels observed throughout he 
study confirmed the stability of the fibroblastic matrix 
on PTFE. Although 11~In uptake by the seeded EC was 
good, 19'26 MC uptake was better. The superior syn- 
thetic capacity of MC compared with EC may explain 
not only their greater initial radioactive substance 
uptake, but also their better etention throughout the 
study after successive washings. Nonetheless, scan- 
ning electron microscopy revealed that although both 
the EC- and MC-seeded prostheses lost radioactive 
substance-labelled cells, the cell population that 
remained adherent to the biomaterial was sufficient o 
cover almost the entire surface. 
We conclude that: 
(a) MC had a greater 11~In uptake and retention than 
EC after seeding on the fibroblastic matrix. 
(b) In spite of successive washings, a large enough 
number of EC and MC remained adherent to the 
matrix to ensure complete covering of the prosthetic 
surface. 
(c) MC can be considered a good alternative to EC for 
seeding prostheses in experimental nimals. 
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